Olivera, G.G.; Yáñez, Y.; Gargallo, P.; Sendra, L.; Aliño, S.F.; Segura, V.; Sanz, M.Á.; Cañete, A.; Castel, V.; Font De Mora, J.;
et al. MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients. Int. J. Mol. Sci. 2020, 21, 2714.
https://doi.org/10.3390/ijms21082714
AMA Style
Olivera GG, Yáñez Y, Gargallo P, Sendra L, Aliño SF, Segura V, Sanz MÁ, Cañete A, Castel V, Font De Mora J,
et al. MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients. International Journal of Molecular Sciences. 2020; 21(8):2714.
https://doi.org/10.3390/ijms21082714
Chicago/Turabian Style
Olivera, Gladys G., Yania Yáñez, Pablo Gargallo, Luis Sendra, Salvador F. Aliño, Vanessa Segura, Miguel Ángel Sanz, Adela Cañete, Victoria Castel, Jaime Font De Mora,
and et al. 2020. "MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients" International Journal of Molecular Sciences 21, no. 8: 2714.
https://doi.org/10.3390/ijms21082714
APA Style
Olivera, G. G., Yáñez, Y., Gargallo, P., Sendra, L., Aliño, S. F., Segura, V., Sanz, M. Á., Cañete, A., Castel, V., Font De Mora, J., Hervás, D., Berlanga, P., & Herrero, M. J.
(2020). MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients. International Journal of Molecular Sciences, 21(8), 2714.
https://doi.org/10.3390/ijms21082714